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Abstract
Introduction
Adipose tissue is considered an important metabolic tissue, in charge of energy storage as
well as being able to act in systemic homeostasis and inflammation. Epigenetics involves a
series of factors that are important for gene regulation or for chromatin structure, mostly
DNA methylation and histone-tail modifications, which can be modified by environmental
conditions (nutrition, lifestyle, smoking. . .). Since metabolic diseases like obesity and diabe-
tes are closely related to lifestyle and nutrition, epigenetic deregulation could play an impor-
tant role in the onset of these diseases and vice versa. However, little is known about
histone marks in human adipose tissue. In a previous work, we developed a protocol for
chromatin immunoprecipitation (ChIP) of frozen human adipose tissue. By using this
method, this study investigates, for the first time, the H3K4 trimethylation (H3K4me3) mark
(open chromatin) on the promoter of several factors involved in adipogenesis, lipid metabo-
lism and inflammation in visceral adipose tissue (VAT) from human subjects with different
degrees of body mass index (BMI) and metabolic disease.
Methodology
VAT was collected and frozen at -80˚C. 100 mg VAT samples were fixed in 0.5% formalde-
hyde and homogenized. After sonication, the sheared chromatin was immune-precipitated
with an anti-H3K4me3 antibody linked to magnetic beads and purified. H3K4me3 enrich-
ment was analyzed by qPCR for LEP, LPL, SREBF2, SCD1, PPARG, IL6, TNF and E2F1
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promoters. mRNA extraction on the same samples was performed to quantify gene expres-
sion of these genes.
Results
H3K4me3 was enriched at the promoter of E2F1, LPL, SREBF2, SCD1, PPARG and IL6 in
lean normoglycemic compared to morbid obese subjects with prediabetes. Accordingly
H3K4me3 mark enrichment at E2F1, LPL, SREBF2, SCD1, PPARG and IL6 promoters was
positively correlated with the BMI and the HOMA-IR. Regression analysis showed a strong
relationship between the BMI with H3K4me3 at the promoter of E2F1 and LPL, and with
mRNA levels of LEP and SCD. In the case of HOMA-IR, the regression analysis showed
associations with H3K4me3 enrichment at the promoter of SCD1 and IL6, and with the
mRNA of LEP and SCD1. Moreover H3K4me3 at the E2F1 promoter was positively associ-
ated to E2F1 mRNA levels.
Conclusions
H3K4me3 enrichment in the promoter of LEP, LPL, SREBF2, SCD1, PPARG, IL6, TNF and
E2F1 is directly associated with increasing BMI and metabolic deterioration. The H3k4me3
mark could be regulating E3F1 mRNA levels in adipose tissue, while no associations between
the promoter enrichment of this mark and mRNA levels existed for the other genes studied.
Introduction
Obesity and related disorders have become one of the greatest health problems in developed
countries. Obesity usually involves an increased risk of metabolic syndrome (MetS), insulin
resistance, diabetes, cardiovascular failure, stroke and some sort of cancers [1].
Adipose tissue, which plays an important role as a lipid storage tissue, has emerged as an
active tissue that can produce a multitude of signaling molecules (cytokines, adipokines, lipids,
. . .) affecting whole body function and participating in the metabolic disruption observed dur-
ing obesity [2]. In addition to its role in metabolic homeostasis, the endocrine-related activity
of this tissue is being currently studied in the context of a large number of diseases like diabe-
tes, MetS, cardiovascular disease or cancer [3,4]. Indeed, obesity is accompanied by an incre-
ment in fat mass proportion, associated with adipose tissue dysfunction and increased
inflammation [3,5]. Moreover, a limited lipid accumulation capacity of adipose tissue can pro-
voke ectopic lipid accumulation, as muscle and liver lipid accumulation, which can result in
insulin resistance, and eventually in type 2 diabetes mellitus [6].
A strong environmental component exists in obesity and related diseases. In this sense, epi-
genetics has been postulated to be an important regulation landscape in this etiology as envi-
ronment factors like lifestyle, smoking or diet have been proposed to modify epigenetic
regulation [7]. Nevertheless, the role of adipose tissue epigenetic modifications in the etiology
of obesity and metabolic disorders has been usually restricted to DNA methylation studies [8].
Adipose tissue chromatin immunoprecipitation (ChIP) for histone marks has been carried out
mostly in mice, and especially in vitro in adipose-derived mesenchymal stem cells. Probably
due to difficulties found in human adipose tissue manipulation, no studies have investigated
(to our knowledge) direct histone modifications in human adipose tissue [8].
In a previous work, we developed a ChIP method to determine H3K4me3 chromatin
immunoprecipitation in small pieces of frozen human adipose tissue [8]. In this study, we
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applied this method to analyze histone methylations in adipose tissue of a cohort of 39 patients
with different metabolic profiles. We analyzed promoter H3K4me3 levels and the gene expres-
sion of specific genes related to lipid metabolism, adipogenesis and inflammation, such as
LEP, LPL, SREBF2, SCD1, PPARG, IL6, TNF and E2F1.
Methodology
Study population
This study was undertaken in 39 subjects, classified according to their BMI and glucose state
as Lean Normoglycemic (Lean NG) (BMI<25 and glucose<100 mg/dl), Morbid Obese Nor-
moglycemic (MO NG) (BMI>40 and glucose<100 mg/dl) and Morbid Obese Prediabetic
(MO PD) (BMI>40 and glucose ranging�100 to<125). Study procedures included a com-
prehensive physical examination and blood analysis. The metabolic parameters for the 3
groups are presented in Table 1.
Study subjects were recruited during 2012–2014 from patients that had undergone laparo-
scopic surgery for elective cholecystectomy, hiatal-hernia surgery, or bariatric surgery. Exclu-
sion criteria included the presence of cardiovascular disease, arthritis, acute inflammatory
disease, infectious disease, renal disease or patients receiving drugs that could alter the lipid
profile or MetS parameters at the time of study inclusion. Smoking habits and alcohol con-
sumption were measured using a standardized questionnaire.
The study was conducted in accordance with the guidelines laid down in the Declaration of
Helsinki. All participants gave their written informed consent and the study was reviewed and
approved by the Ethics and Research Committee of Virgen de la Victoria Hospital.
Laboratory measurements
Serum parameters were measured following previous procedures [9]. Leptin and adiponectin
were analyzed by enzyme immunoassay (ELISA) kits (DSL, Webster, TX, and DRG Diagnos-
tics GmbH, Germany, respectively).
Table 1. Anthropometric and biochemical variables for each study group. Different letters mean significant differ-
ences between groups (p<0.05).
Lean NG (n = 10) MO NG (n = 10) MO PD (n = 9)
Age (years) 54.40±13.93 40.50±8.34 47.11±8.28
Gender (male/female) 4/6 3/7 3/6
BMI (kg/m2) 22,91±1.52a 50,70±8.78b 56.12±7.99b
Waist (cm) 86.70±8.74a 134.70±20.27b 142.74±14.41b
Glucose (mg/dl) 91.10±6.04a 90,90±4.95a 111.89±4.37b
Insulin (pmol/L) 6.02±3.13a 20.26±15.61b 22.29±9.10b
HOMA-IR 1,34±0.69a 4.61±3.53b 6.14±2.48b
Cholesterol (mg/dl) 226.30±56.60 183.10±48.66 190.44±25.48
HDL-C (mg/dl) 56.20±16.81a 41.20±9.37a,b 39.67±5.54b
LDL-C (mg/dl) 144.46±45.19 120.84±45.76 120.16±22.17
Tg (mg/dl) 128.40±69.38 93.99±31.09 159.53±60.84
SBP (mm Hg) 129.90±25.00 135.44±30.73 141.29±15.15
DBP (mm Hg) 80.80±9.36 80.78±13.04 86.86±9.22
Body mass index (BMI); Homeostatic model assessment of insulin resistance (HOMA-IR); High-density lipoprotein
cholesterol (HDL-C); Low-density lipoprotein cholesterol (LDL-C); Triglycerides (Tg); Postprandial triglycerides (Tg
Post); Systolic blood pressure (SBP); Diastolic blood pressure (DBP).
https://doi.org/10.1371/journal.pone.0215083.t001
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Visceral adipose tissue RNA isolation
VAT was obtained during laparoscopic surgery. Biopsy samples were washed in physiological
saline buffer and immediately frozen in liquid nitrogen. Biopsy samples were maintained at
−80˚C until analysis.
Real-time quantitative PCR
RNA extraction and qPCR analysis was performed as described previously [9]. For the gene
expression we used the following commercial assays LEP (Hs00174877_m1, RefSeq.
NM_000230.2), LPL (Hs00173425_m1, RefSeq. NM_000237.2), SREBF2 (Hs01081784_m1,
RefSeq. NM_004599.3), SCD1 (Hs01682761_m1, RefSeq. NM_005063.4), PPARG
(Hs01115513_m1, RefSeq. NM_005037.5, NM_015869.4, NM_138711.3, NM_138712.3), IL6
(Hs00174131_m1, RefSeq. NM_000600.4, NM_001318095.1), TNF (Hs01113624_g1, RefSeq.
NM_000594.3) and E2F1 (Hs00153451_m1, RefSeq. NM_005225.2). PPIA (4326316E) was
used as endogenous control.
Chromatin immunoprecipitation assay
ChiP was performed as previously described [8]. Briefly, 100 mg of frozen VAT was fixed in
0.5% formaldehyde for 5 minutes and the reaction was stopped by adding a final concentration
of 0.125 mM of glycine and incubated for 5 minutes. After homogenizing the sample in cell
lysis buffer the nucleus phase was pelleted and then suspended in nucleus lysis buffer [8]. Sam-
ples were then sheared by sonication (Bioruptor UCD-300, Diagenode) and the chromatin
concentration and chromatin fragments were checked using Nanodrop and 2% agarose gel.
Then, samples were immunoprecipitated using an anti-H3K4me3 antibody (ab8580, abcam)
linked to magnetic beads (Dynabeads Protein G, Thermofisher) and the DNA purified with
MinElute PCR Purification Kit (Qiagen). Specific promoter H3K4me3 was performed using
the primer sets depicted in [8] and the following primer set for E2F1 promoter quantification:
Sense: AGGAACCGCCGCCGTTGTTCCCG, Antisense: CTGCCTGCAAAGTCCCGGC-
CACTT. The normalized enrichment value was calculated as the subtraction of the IP relative
value with the Input relative value. The IP and Input relative values were calculated by compar-
ing the normalized enrichment values obtained from the standard curves.
Statistical analyses
Comparisons between groups were calculated using Kruskal-Wallis test for non-normal distri-
bution variables, and Mann-Whitney U-test for the group-by-group comparisons. Spearman’s
correlation coefficients were calculated to evaluate the association between the study variables
in the whole population. The variable named “MetS variables” defined the number of MetS
components present in each individual, which ranged from 0–5, as described by [10]. Values
were considered to be statistically significant when P< 0.05. The analyses were performed
with SPSS (Version 15.0 for Windows; SPSS).
Results and discussion
In this work, we studied for the first time the H3K4me3 histone mark at several gene promot-
ers for genes associated with adipogenesis, lipid metabolism and inflammation in human adi-
pose tissue. We identified histone modification (H3K4me3) in a population classified into
three groups according to their BMI and glucose metabolic status: Lean NG, MO NG and MO
PD. A description of the anthropometric and biochemical variables of these groups is given in
Human adipose H3K4me3 according to BMI and glucose
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Fig 1. Group comparisons of H3K4me3 mark enrichment at the promoter of the study genes. Different letters indicate
significant differences between the means of the different groups of subjects (p < 0.05; a: Lean NG vs. MO NG; b: Lean NG
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Table 1. Statistical differences were observed between groups for BMI, waist circumference
and the serum levels of glucose, insulin, HOMA-IR and HDL-C (Table 1).
Regarding enrichment of the H3K4me3 mark, we observed an increased enrichment at
E2F1, LPL, SREBF2, SCD1, PPARG and IL6 promoters in the MO PD group compared to the
Lean NG group (Fig 1). Concerning the gene expression, LPL, SCD1 and PPARG mRNA levels
were lower in the MO PD group than the Lean NG group (Fig 2); whereas higher mRNA levels
for IL6 and TNF genes were noted in MO PD compared to Lean NG subjects (Fig 2).
A positive correlation between the H3K4me3 mark at E2F1, LPL, SREBF2, SCD1, PPARG
and IL6 promoters and the BMI and HOMA-IR was observed (Table 2 and S1 Fig). Moreover,
there was a positive correlation between glucose and H3K4me3 mark enrichment at the pro-
moter of SCD1, PPARG, E2F1 and IL6 (Table 2 and S1 Fig). The association between the
H3K4me3 mark and glucose has been studied in the promoter of the inflammatory gene NFkB
p65 in Set7 KD cells, where a decrease of the H3K4me3 mark associated with glucose supple-
mentation was observed [11]. This is in agreement with our findings, showing a positive corre-
lation between promoter H3H4me3 increase and the HOMA-IR. In addition, we also
observed a positive correlation between the H3K4me3 mark at E2F1, SREBF2 and SCD pro-
moters and the number of MetS components (MetS Var) present (Table 2 and S1 Fig).
Regarding the correlation between the gene expression and clinical variables, BMI was posi-
tively associated with LEP, IL6 and TNF mRNA levels while it was negatively correlated with
LPL, SCD1 and PPARG mRNA (Table 3 and S2 Fig). HOMA-IR correlated with LEP, IL6 and
TNF mRNA positively, and negatively with SREBF2 and SCD (Table 3 and S2 Fig). These
results are in line with the scientific literature, since a negative association between LPL and
PPARG mRNA and the BMI has been described previously [9,12]. In addition, BMI and insu-
lin resistance have been associated with a low-grade inflammation in adipose tissue [13–15],
which is in accordance with the positive relationship between these two parameters and the
inflammatory markers measured in this work. Positive associations were described between
HDL-C and LPL, SCD1 and PPARG gene expressions (Table 3 and S2 Fig). Interestingly,
E2F1 mRNA levels were negatively associated with all cholesterol variables, total cholesterol
(Chol), HDL-C and LDL-C (Table 3). E2F1 has been shown to regulate lipid and cholesterol
metabolism in the liver and to participate in cholesterol withdrawal [16,17].
Finally, a harmonized lineal regression analysis showed that BMI was greatly explained by
H3K4me3 enrichment levels at the promoter of E2F1 and LPL, and by the mRNA levels of
LEP and SCD (Table 4). In this model, these four variables could explain up to 83% of the BMI
variability present in our study population (Table 4). Similarly, another harmonized lineal
regression analysis (with HOMA-IR as dependent variable) showed that H3K4me3 enrich-
ment levels at the promoter of SCD1 and IL6, together with the mRNA levels of LEP and
SCD1, could explain 79% of the variation observed in the HOMA-IR (Table 5).
The H3K4me3 level depends on the methylation and de-methylation processes, which are
carried out by several methyltransferases and de-methyltransferases [7], and that in turn
depend on substrate disposal [18]. S-Adenosyl methionine (SAM) is a methyl-group molecular
donor for a wide range of reactions, including methylation processes and has been shown to
be altered according to nutritional and cell metabolism status affecting H3K4me3 levels [19].
It has been shown that SAM levels increase with the BMI, and that this increase is associated
vs. MO PD; c: MO NG vs. MO PD) according to Mann Whitney U test. Abbreviations: Lean Normoglycemic (Lean NG);
Morbid obese normoglycemic (MO NG); Morbid obese prediabetic (MO PD); E2F transcription factor 1 (E2F1);
Lipoprotein Lipase (LPL); Sterol regulatory element-binding factor 2 (SREBF2); Stearoyl-CoA desaturase 1 (SCD1);
Peroxisome proliferator-activated receptor gamma (PPARG); Interleukin 6 (IL6); Tumor necrosis factor (TNF).
https://doi.org/10.1371/journal.pone.0215083.g001
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with adiposity [20]. Therefore, a possible increase in SAM associated with the BMI could
explain the increase in the H3K4me3 mark found in E2F1, LPL, SREBF2, SCD1, PPARG and
IL6 gene promoters of the MO PD group with respect to the Lean NG group. Moreover, in our
population the differences in the H3K4me3 enrichment levels for the genes associated with
BMI and HOMA-IR might be related to substrate fluctuations, even though it has been shown
that sensitivity of histone methylation to methyl group availability is site-specific [18]. Accord-
ingly, the fluctuation in the H3K4me3 mark observed in this study could be related with the
metabolic status since energy and metabolic intermediaries have been related to histone meth-
ylation, which could be in tune with adipose tissue dysfunction.
De-methylation processes can also modulate H3K4me3 mark levels. The reduction in
fatty acid oxidation and glucose incorporation observed in insulin resistance states [21–23]
together with the adipose tissue hypoxia in the context of metabolic diseases and insulin
resistance [24] could affect H3K4me3 mark levels by down-regulating histone de-methyla-
tion. In fact, hypoxia has been reported to increase H3K4me3 marks through reduction of
de-methylation [18].
In order to analyze whether the promoter H3K4me3 mark levels could be related to gene
expression we performed Spearman’s correlation analysis in the whole population between the
mRNA levels and H3K4me3 mark at each gene. However, we did not observe any significant
association between the promoter H3K4me3 levels and the mRNA levels for any gene excepting
E2F1, in which a positive correlation was observed (r = 0.422, p = 0.04). H3K4me3 is a mark
associated with a condition of open chromatin and consequently stimulates gene expression
[25]. Thus, this positive association observed between this mark at the promoter of E2F1 and
the mRNA levels for this gene suggests that this gene could be transcriptionally controlled by
this epigenetic mark in adipose tissue. Adipose tissue E2F1 has been shown to be overexpressed
in obesity, leading to inflammation and metabolic deterioration [26,27]. Thus, the H3K4me3
Fig 2. Group comparisons of the relative mRNA levels of the study genes. Different letters indicate significant differences
between the means of the different groups of subjects (p < 0.05; a: Lean NG vs. MO NG; b: Lean NG vs. MO PD; c: MO NG
vs. MO PD) according to Mann Whitney U test. Abbreviations: Lean Normoglycemic (Lean NG); Morbid obese
normoglycemic (MO NG); Morbid obese prediabetic (MO PD); E2F transcription factor 1 (E2F1); Lipoprotein Lipase (LPL);
Sterol regulatory element-binding factor 2 (SREBF2); Stearoyl-CoA desaturase 1 (SCD1); Peroxisome proliferator-activated
receptor gamma (PPARG); Interleukin 6 (IL6); Tumor necrosis factor (TNF).
https://doi.org/10.1371/journal.pone.0215083.g002
Table 2. Spearman correlation analysis between H3K4me3 mark enrichment at the study gene promoters and the anthropometric and biochemical variables. � and
�� mean p<0.05 and p<0.01 respectively.
H3K4me3 enrichment Age BMI Glucose Insulin HOMA-IR Tg Chol HDL-C LDL-C SBP DBP MetS Var
E2F1 -0.214 0.530�� 0.552�� 0.573�� 0.594�� -0.01 -0.256 -0.163 -0.257 0.123 0.072 0.448�
LEP -0.148 0.364 0.361 0.348 0.367 0.044 -0.133 -0.12 -0.143 0.075 0.006 0.279
LPL -0.168 0.430� 0.395� 0.437� 0.463� -0.008 -0.208 -0.141 -0.198 0.154 0.064 0.333
SREBF2 -0.236 0.467� 0.442� 0.403� 0.441� -0.048 -0.178 -0.232 -0.113 0.088 0.062 0.463�
SCD -0.242 0.528�� 0.513�� 0.529�� 0.548�� -0.034 -0.214 -0.186 -0.213 0.157 0.071 0.420�
PPARG -0.243 0.488�� 0.399� 0.460� 0.479�� -0.051 -0.263 -0.212 -0.246 0.073 0.038 0.369
IL6 -0.131 0.430� 0.497�� 0.472� 0.501�� 0.062 -0.094 -0.15 -0.065 0.191 0.047 0.327
TNF 0.009 0.23 0.379� 0.295 0.305 -0.051 -0.093 -0.008 -0.105 0.085 0.056 0.163
E2F transcription factor 1 (E2F1); Leptin (LEP); Lipoprotein Lipase (LPL); Sterol regulatory element-binding factor 2 (SREBF2); Stearoyl-CoA desaturase 1 (SCD1);
Peroxisome proliferator-activated receptor gamma (PPARG); Interleukin 6 (IL6); Tumor necrosis factor (TNF); Body mass index (BMI); Homeostatic model assessment
of insulin resistance (HOMA-IR); Triglycerides (Tg); Total cholesterol (Chol); High-density lipoprotein cholesterol (HDL-C); Low-density lipoprotein cholesterol
(LDL-C); Systolic blood pressure (SBP); Diastolic blood pressure (DBP); Number of MetS variables (MetS Var).
https://doi.org/10.1371/journal.pone.0215083.t002
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mark level might depend on the metabolic status of the patients, and the possible increase of
this mark at E2F1 promoter could in turn be related to the worsening in the metabolic status
through direct stimulation of E2F1 expression. With respect to the other genes studied, further
studies will be necessary to explain their complex epigenetic regulation, for instance through
the study together with other histone marks like H3K27m3 (related to heterochromatin and
gene repression), the study of DNA methylation at their promoter or ChIP followed by deep
sequencing (ChIPseq), which could highlight a more accurate regulatory state of the promoters
[28,29]. Other authors have previously described that there are expressed genes where the mark
is absent and genes with the mark that are not expressed, showing that the presence of the mark
is neither necessary nor sufficient for gene expression even though genes marked with
H3K4me3 have a higher average levels of mRNA [30].
Nevertheless, chromosome conformation is important for the genetic regulation in adipo-
cytes [31], a process that might be influenced by H3K4me3 mark modifications [32,33]. Chro-
mosome deregulation has been widely associated with several diseases, some associated with
H3K4me3 methylases or H3K4me3 modifier deregulation [7]. In fact, abnormal H3K4me3
marks in brain tissue have been observed in the context of Huntington’s disease without the
existence of a correlation between the difference in H3K4me3 peaks observed with their asso-
ciated gene expression [34], similar to our results in VAT. In this sense, histone modifications
Table 3. Spearman correlation analysis between the relative mRNA levels at the study genes and the anthropometric and biochemical variables. � and �� mean
p<0.05 and p<0.01 respectively.
Relative mRNA Age BMI Glucose Insulin HOMA-IR Tg Chol HDL-C LDL-C SBP DBP MetS Var
E2F1 -0.256 0.359 0.116 0.194 0.19 -0.151 -0.559�� -0.407� -0.534�� -0.144 0.097 0.284
LEP -0.321 0.522�� 0.334 0.673�� 0.683�� 0.179 -0.213 -0.308 -0.093 0.04 -0.095 0.533��
LPL 0.103 -0.500�� -0.295 -0.33 -0.327 -0.189 0.31 0.516�� 0.203 0.008 -0.102 -0.454�
SREBF2 0.088 -0.258 -0.178 -0.391� -0.409� -0.238 -0.082 -0.024 -0.069 -0.209 -0.238 -0.373
SCD 0.375� -0.681�� -0.319 -0.526�� -0.525�� -0.124 0.381� 0.555�� 0.277 0.054 -0.165 -0.597��
PPARG 0.061 -0.408� -0.214 -0.216 -0.204 -0.112 0.221 0.371� 0.182 0.097 0.161 -0.28
IL6 -0.291 0.729�� 0.486� 0.571�� 0.590�� 0.036 -0.285 -0.223 -0.322 -0.025 0.144 0.533��
TNF -0.298 0.679�� 0.322 0.594�� 0.612�� 0.024 -0.263 -0.175 -0.335 0.048 -0.108 0.444�
E2F transcription factor 1 (E2F1); Leptin (LEP); Lipoprotein Lipase (LPL); Sterol regulatory element-binding factor 2 (SREBF2); Stearoyl-CoA desaturase 1 (SCD1);
Peroxisome proliferator-activated receptor gamma (PPARG); Interleukin 6 (IL6); Tumor necrosis factor (TNF); Body mass index (BMI); Homeostatic model assessment
of insulin resistance (HOMA-IR); Triglycerides (Tg); Total cholesterol (Chol); High-density lipoprotein cholesterol (HDL-C); Low-density lipoprotein cholesterol
(LDL-C); Systolic blood pressure (SBP); Diastolic blood pressure (DBP); Number of MetS variables (MetS Var).
https://doi.org/10.1371/journal.pone.0215083.t003
Table 4. Harmonized lineal regression analysis with BMI as dependent variable. H3K4me3 mark enrichment at
gene promoters and gene expression of genes that showed significant association in the Spearman correlation analysis
were introduced in the model, which was corrected for age and sex.
BMI (R = 0.91, R2 = 0.83)
Beta p 95% CI
E2F1 H3K4me3 0.979 0.001 0.844 to 2.922
LPL H3K4me3 -0.813 0.003 -3.640 to -0.840
LEP mRNA 0.344 0.002 38.32 to 152.97
SCD mRNA -0.516 0.000 -3.650 to -1.459
Body mass index (BMI); E2F transcription factor 1 (E2F1); Lipoprotein Lipase (LPL); Leptin (LEP); Stearoyl-CoA
desaturase 1 (SCD1).
https://doi.org/10.1371/journal.pone.0215083.t004
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could not only be important for gene expression regulation but also for chromosome stability,
DNA replication or chromosome segregation [35].
However, the cross-sectional nature of our study represents a limitation and more studies
using ChiP-seq, metabolomic approaches and animal models are necessary to establish the
role of the H3K4me3 mark in VAT and how the metabolic status could be affecting H3K4me3
(and other histone marks) levels.
As strengths, in this work we study for the first time H3k4me3 after ChIP in human adipose
tissue, a metabolic tissue in which histone characterization is yet to be performed due to its
lipid nature which hinders downstream manipulation [8].
In conclusion, we applied for the first time the adipose tissue ChIP protocol to determine
the histone H3K4 trimethylation modification at the promoter of several adipogenic, lipid
metabolism and inflammatory genes in human VAT in a population with different degrees of
BMI and glucose metabolism. We found an increase in the H3K4me3 mark at E2F1, LPL,
SREBF2, SCD1, PPARγ and IL6 promoters as the BMI and HOMA-IR increased. Moreover,
enrichment at these promoters was positively associated with BMI, HOMA-IR and MetS wors-
ening. Interestingly, E2F1 mRNA expression and the H3K4me3 mark level correlated posi-
tively, suggesting a transcriptional control of this gene by this histone modification in VAT,
contributing to VAT inflammation and deterioration in obesity and metabolic diseases. Thus,
this work points out the importance of epigenetics in discerning complex metabolic diseases
and obesity, and gives clues to a more comprehensive and in depth analysis about the possible
role of adipose tissue histone code within the context of these disorders, which could lead to
possible epigenetic therapies.
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